| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6889331
[patent_doc_number] => 20010024786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'Human peroxisomal thioesterase'
[patent_app_type] => new
[patent_app_number] => 09/766366
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19209
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20010024786.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766366
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766366 | Human peroxisomal thioesterase | Jan 17, 2001 | Abandoned |
Array
(
[id] => 6896010
[patent_doc_number] => 20010026800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Selective activation of a TH1 or TH2 lymphocyte regulated immune response'
[patent_app_type] => new
[patent_app_number] => 09/757311
[patent_app_country] => US
[patent_app_date] => 2001-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6982
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20010026800.pdf
[firstpage_image] =>[orig_patent_app_number] => 09757311
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/757311 | Selective activation of a TH1 or TH2 lymphocyte regulated immune response | Jan 7, 2001 | Abandoned |
| 09/647180 | Nucleic acid and amino acid sequences | Jan 2, 2001 | Abandoned |
Array
(
[id] => 6892345
[patent_doc_number] => 20010018507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Tumour necrosis factor binding ligands'
[patent_app_type] => new
[patent_app_number] => 09/736792
[patent_app_country] => US
[patent_app_date] => 2000-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13702
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018507.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736792
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736792 | Tumor necrosis factor antibodies | Dec 12, 2000 | Issued |
Array
(
[id] => 6892346
[patent_doc_number] => 20010018508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Tumour necrosis factor binding ligands'
[patent_app_type] => new
[patent_app_number] => 09/737121
[patent_app_country] => US
[patent_app_date] => 2000-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13691
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018508.pdf
[firstpage_image] =>[orig_patent_app_number] => 09737121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/737121 | Tumor necrosis factor antibodies | Dec 12, 2000 | Issued |
Array
(
[id] => 1570762
[patent_doc_number] => 06498237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-24
[patent_title] => 'Tumor necrosis factor antibodies'
[patent_app_type] => B2
[patent_app_number] => 09/736793
[patent_app_country] => US
[patent_app_date] => 2000-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 41
[patent_no_of_words] => 13763
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498237.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736793
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736793 | Tumor necrosis factor antibodies | Dec 12, 2000 | Issued |
Array
(
[id] => 1338922
[patent_doc_number] => 06593458
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Tumor necrosis factor peptide binding antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/736630
[patent_app_country] => US
[patent_app_date] => 2000-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 41
[patent_no_of_words] => 13556
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593458.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736630
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736630 | Tumor necrosis factor peptide binding antibodies | Dec 12, 2000 | Issued |
Array
(
[id] => 6083004
[patent_doc_number] => 20020082396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Reshaped human antibody to human interleukin-8'
[patent_app_type] => new
[patent_app_number] => 09/730857
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17554
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082396.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730857
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730857 | Reshaped human antibody to human interleukin-8 | Dec 6, 2000 | Abandoned |
Array
(
[id] => 6875748
[patent_doc_number] => 20010000075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-03-29
[patent_title] => 'Neurotactin and uses therefor'
[patent_app_type] => new-utility
[patent_app_number] => 09/728401
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20241
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0000/20010000075.pdf
[firstpage_image] =>[orig_patent_app_number] => 09728401
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/728401 | Neurotactin and uses therefor | Nov 30, 2000 | Abandoned |
Array
(
[id] => 6875122
[patent_doc_number] => 20010000241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-04-12
[patent_title] => 'Antibodies to human G-protein chemokine receptor HDGNR10 (CCR5 receptor)'
[patent_app_type] => new-utility
[patent_app_number] => 09/725285
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12718
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0000/20010000241.pdf
[firstpage_image] =>[orig_patent_app_number] => 09725285
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/725285 | Antibodies to human G-protein chemokine receptor HDGNR10 (CCR5 receptor) | Nov 28, 2000 | Abandoned |
| 09/724240 | Methods for targeting cells that express fibroblast growth receptor-3 or -2 | Nov 27, 2000 | Abandoned |
| 09/722064 | Novel antibodies and ligands for bonzo chemokine receptor | Nov 21, 2000 | Abandoned |
| 09/698435 | Methods for treating transplant rejection | Oct 26, 2000 | Abandoned |
Array
(
[id] => 1535629
[patent_doc_number] => 06489453
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Chandra: a TH1-specific gene'
[patent_app_type] => B1
[patent_app_number] => 09/694094
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24733
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489453.pdf
[firstpage_image] =>[orig_patent_app_number] => 09694094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/694094 | Chandra: a TH1-specific gene | Oct 19, 2000 | Issued |
| 09/692504 | TCCR MEDIATED T-CELL DIFFERENTIATION | Oct 17, 2000 | Abandoned |
| 09/691654 | Recombinant antibody fragments as autoantibody antagonists | Oct 16, 2000 | Abandoned |
Array
(
[id] => 1316387
[patent_doc_number] => 06605280
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-12
[patent_title] => 'Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18'
[patent_app_type] => B1
[patent_app_number] => 09/485632
[patent_app_country] => US
[patent_app_date] => 2000-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 21235
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605280.pdf
[firstpage_image] =>[orig_patent_app_number] => 09485632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/485632 | Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18 | Oct 11, 2000 | Issued |
| 09/684601 | Novel therapy for antibody-mediated inflammatory auto-immune disorders | Oct 5, 2000 | Abandoned |
Array
(
[id] => 1416387
[patent_doc_number] => 06525180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Antibodies to mammalian T cell surface antigen'
[patent_app_type] => B1
[patent_app_number] => 09/671658
[patent_app_country] => US
[patent_app_date] => 2000-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15538
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525180.pdf
[firstpage_image] =>[orig_patent_app_number] => 09671658
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/671658 | Antibodies to mammalian T cell surface antigen | Sep 26, 2000 | Issued |
Array
(
[id] => 1418356
[patent_doc_number] => 06521749
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'GL50 nucleic acids and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/667135
[patent_app_country] => US
[patent_app_date] => 2000-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 80
[patent_no_of_words] => 62315
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521749.pdf
[firstpage_image] =>[orig_patent_app_number] => 09667135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/667135 | GL50 nucleic acids and uses therefor | Sep 20, 2000 | Issued |
